Adial Pharmaceuticals ' Potential Treatment For Alcohol Use Disorder Shows Encouraging Safety, Patient Compliance

Wednesday, Adial Pharmaceuticals Inc ADIL announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high compliance among patients administered AD04 (low-dose ondansetron). AD04 is the company’s lead investigational new drug product being…#alcoholusedisorder #aud #phase3 #alt #ast #serumbilirubin #adialpharmaceuticals #adial
Source: Reuters: Health - Category: Consumer Health News Source Type: news